- Home
- ABVC vs AMS Comparison
ABVC vs AMS Comparison
Compare ABVC & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVC
- AMS
- Stock Information
- Founded
- ABVC 2015
- AMS 1980
- Country
- ABVC United States
- AMS United States
- Employees
- ABVC N/A
- AMS N/A
- Industry
- ABVC Biotechnology: Pharmaceutical Preparations
- AMS Medical Specialities
- Sector
- ABVC Health Care
- AMS Health Care
- Exchange
- ABVC Nasdaq
- AMS Nasdaq
- Market Cap
- ABVC 18.8M
- AMS 17.9M
- IPO Year
- ABVC N/A
- AMS N/A
- Fundamental
- Price
- ABVC $1.46
- AMS $2.98
- Analyst Decision
- ABVC
- AMS
- Analyst Count
- ABVC 0
- AMS 0
- Target Price
- ABVC N/A
- AMS N/A
- AVG Volume (30 Days)
- ABVC 248.3K
- AMS 7.0K
- Earning Date
- ABVC 04-30-2025
- AMS 05-15-2025
- Dividend Yield
- ABVC N/A
- AMS N/A
- EPS Growth
- ABVC N/A
- AMS 243.96
- EPS
- ABVC N/A
- AMS 0.33
- Revenue
- ABVC $508,383.00
- AMS $28,340,000.00
- Revenue This Year
- ABVC $735.18
- AMS $23.63
- Revenue Next Year
- ABVC N/A
- AMS N/A
- P/E Ratio
- ABVC N/A
- AMS $8.76
- Revenue Growth
- ABVC 1904.43
- AMS 32.90
- 52 Week Low
- ABVC $0.40
- AMS $2.51
- 52 Week High
- ABVC $1.40
- AMS $4.60
- Technical
- Relative Strength Index (RSI)
- ABVC 64.11
- AMS 61.91
- Support Level
- ABVC $1.18
- AMS $2.68
- Resistance Level
- ABVC $1.36
- AMS $2.80
- Average True Range (ATR)
- ABVC 0.14
- AMS 0.08
- MACD
- ABVC 0.05
- AMS 0.02
- Stochastic Oscillator
- ABVC 63.74
- AMS 94.12
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.